Bringing a new chemical entity, drug, or device to the consumer market is a necessary but intricate, expensive, complicated, and time-consuming process. There are different avenues of drug discovery and product development and many aspects of development focus on satisfaction of regulatory requirements mandated by the FDA and other regulatory agencies.
According to the 2015 US National Diabetes Statistics Report, 30.2 million persons aged 18 years and older with diagnosed (23.1 million) and undiagnosed (7.2 million) type 1 and 2 diabetes were at higher risk for developing vaccine-preventable diseases such as pneumonia. Although the decision to receive vaccines is still a patient’s choice, as one of the most accessible health care professionals, pharmacists are instrumental in providing patients with pertinent information to make informed choices when it comes to immunizations, in terms of the benefits as well as the risks. Pharmacists are also in a unique position to identify those patients who are in target groups for certain vaccinations such as patients with chronic conditions like Diabetes. Pharmacists may also help ease the fears of many patients by providing them with the facts as well as the significant risks associated with getting vaccinated.
Type 2 diabetes mellitus (DM) globally affects 18–20% of adults over the age of 65 years. In the Philippines, diabetes is currently one of the most pressing public health concerns with a 2009 cohort study showing a 9-year incidence of Type 2 DM at 16.3% and a prevalence of 28.0%. The Philippines is also considered one of the diabetes hotspots in the Western Pacific Region, where the disease is approaching epidemic proportions. Further, diabetes is also associated with several complications such as diabetic kidney disease (DKD), one of the most frequent and dangerous complications of diabetes mellitus type 2, affecting about one-third of the patients with Type 2 DM.